Trimebutine

Chemical formula: C₂₂H₂₉NO₅  Molecular mass: 387.476 g/mol  PubChem compound: 5573

Therapeutic indications

Trimebutine is indicated for:

Irritable bowel syndrome

Population group: only adults (18 years old or older)

Trimebutine maleate is indicated for the treatment and relief of symptoms associated with the irritable bowel syndrome (spastic colon).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Postoperative paralytic ileus

Population group: only adults (18 years old or older)

Trimebutine maleate is indicated in postoperative paralytic ileus in order to accelerate the resumption of the intestinal transit following abdominal surgery.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈